THE D1 RECEPTOR AND COGNITION AND TRIAL OF A NOVEL D1 AGONIST IN THE SCHIZOPHRENIA SPECTRUM

被引：0
|
作者：
Siever, Larry J. [1 ]
Rosell, Daniel [2 ]
McClure, Margaret [2 ]
Strike, Katherine [3 ]
Barch, Deanna M. [4 ,5 ]
Harvey, Philip [6 ]
Girgis, Ragy [7 ]
Lieberman, Jeffrey [8 ]
Giakoumaki, Stella
Bitsios, Panos
Roussos, Panos [3 ,9 ]
Haroutunian, Vahram [2 ,3 ]
机构：
[1] James J Peters VAMC, Mt Sinai Sch Med, New York, NY USA
[2] James J Peters VAMC, Dept Mental Hlth, New York, NY USA
[3] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
[4] Washington Univ, Dept Psychol, St Louis, MO 63130 USA
[5] Washington Univ, Dept Psychiat, St Louis, MO USA
[6] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA
[7] Columbia Univ, Dept Mental Hlth Serv, New York, NY USA
[8] Columbia Univ, Dept Psychiat, New York, NY USA
[9] Univ Crete, Dept Psychiat & Behav Sci, Iraklion, Greece
来源：
SCHIZOPHRENIA RESEARCH | 2014年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [31] CLOPENTHIXOL TREATMENT OF SCHIZOPHRENIA INCREASES DOPAMINE D1 RECEPTOR DENSITY
    REYNOLDS, GP
    CZUDEK, C
    SCHIZOPHRENIA RESEARCH, 1992, 6 (02) : 137 - 137
  • [32] Prefrontal dopamine transmission in schizophrenia:: Is D1 receptor A relevant biomarker?
    Abi-Dargham, A
    Guo, N
    Narendran, R
    Hwang, D
    Ekelund, J
    Guillin, O
    Martinez, D
    Frankle, G
    Laruelle, M
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 : S13 - S13
  • [33] Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors
    Dall'Olio, R
    Gaggi, R
    Voltattorni, M
    Tanda, A
    Gandolf, O
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (08): : 633 - 638
  • [34] A NOVEL DERIVATIVE OF THE PROSTHETIC GROUP HEME D1 - S-METHYLPORPHYRINDIONE D1
    TIMKOVICH, R
    CARLIN, RT
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1116 (01) : 24 - 26
  • [35] (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions
    Jin, GZ
    Zhu, ZT
    Fu, Y
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (01) : 4 - 7
  • [36] Neurochemical changes in dopamine D1, D3 and D1/D3 receptor knockout mice
    Wong, JYF
    Clifford, JJ
    Massalas, JS
    Finkelstein, DI
    Horne, MK
    Waddington, JL
    Drago, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 472 (1-2) : 39 - 47
  • [37] Intrinsic activity of D1 agonists in the heterozygous genotype of D1 receptor deficient mice.
    Montague, DM
    Drago, J
    Mailman, RB
    FASEB JOURNAL, 1998, 12 (04): : A155 - A155
  • [38] Agonist-regulated phosphorylation and traficking of the dopamine D1 receptor.
    Mason, JN
    Neve, KA
    FASEB JOURNAL, 1999, 13 (04): : A462 - A462
  • [39] D1 Receptor Agonist DAR-0100A and Cortical Gamma Oscillations
    Cho, Raymond
    Polizzotto, Nicola
    Jessen, Zachary
    Walker, Christopher
    Girgis, Ragy
    Abi-Dargham, Anissa
    Lieberman, Jefferey
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S449 - S449
  • [40] Asymmetric synthesis of the dopamine D1 agonist, dihydrexidine
    Hajra, Saumen
    Bar, Sukanta
    TETRAHEDRON-ASYMMETRY, 2011, 22 (07) : 775 - 779
12345